0000886163-17-000108.txt : 20170825
0000886163-17-000108.hdr.sgml : 20170825
20170825173615
ACCESSION NUMBER: 0000886163-17-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170823
FILED AS OF DATE: 20170825
DATE AS OF CHANGE: 20170825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aryeh Jason
CENTRAL INDEX KEY: 0001376960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 171052792
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_150369696228577.xml
FORM 4
X0306
4
2017-08-23
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001376960
Aryeh Jason
3911 SORRENTO VALLEY BOULEVARD
SUITE 110
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2017-08-23
4
S
0
2000
127.99
D
114651
I
Indirect
Common Stock
59625
D
Common Stock
5025
I
by Trust
These securities are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds.
By: Charles S. Berkman For: Jason Aryeh
2017-08-25